The natural history of beryllium sensitization and chronic beryllium disease

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 5, 1996, Pages 937-943

  Newman, Lee S ^a,b   Lloyd, Jenifer ^a   Daniloff, Elaine ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Beryllium; Cell mediated immunity; Chronic beryllium disease; Granuloma; Immunology; Lung disease; Lymphocyte; Metal toxicity; Natural history; Pulmonary

Indexed keywords

BERYLLIUM;

BERYLLIOSIS; CONFERENCE PAPER; GRANULOMA; IMMUNOPATHOGENESIS; LUNG DISEASE; PRIORITY JOURNAL; SENSITIZATION;

EID: 0029827342     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s5937     Document Type: Conference Paper

References (29)

1. Kreiss K, Miller F, Newman LS, Ojo-Amaize EA, Rossman MD, Saltini C. Chronic beryllium disease: from the workplace to cellular immunology, molecular immunogenetics, and back. Clin Immunol Immunopathol 71:123-129 (1994).
2. Kreiss K, Newman LS, Mroz MM, Campbell PA. Screening blood test identifies subclinical beryllium disease. J Occup Med 31:603-608 (1989).
3. Kreiss K, Wasserman S, Mroz MM, Newman LS. Beryllium disease screening in the ceramics industry: blood test performance and exposure-disease relations. J Occup Med 35:267-274 (1993).
4. Kreiss K, Mroz MM, Zhen B, Martyny J, Newman LS. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis 148:985-991 (1993).
5. Cullen MR, Kominsky JR, Rossman MD, Cherniack MG, Rankin JA, Balmes JR, Kern J, Daniele RP, Palmer L, Naegel GP, McManus K, Cruz R. Chronic beryllium disease in a precious metal refinery: clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume. Am Rev Respir Dis 135:201-208 (1987).
6. Newman LS, Kreiss K, King TE Jr, Seay S, Campbell PA. Pathologic and immunologie alterations in early stages of beryllium disease: re-examination of disease definition and natural history. Am Rev Respir Dis 139:1479-1486 (1989).
7. Newman LS, Mroz MM, Lezotte DC, Campbell PA, Kreiss K. Re-examination of the peripheral blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. Am Rev Respir Dis (Suppl) 143:A103 (1991).
8. Sterner JH, Eisenbud M. Epidemiology of beryllium intoxication. Arch Industr Hyg Occup Med 4:123-151 (1951).
9. Newman LS, Mroz MM, Schumacher B, Daniloff E, Kreiss K. Beryllium sensitization precedes chronic beryllium disease. Am Rev Respir Dis (Suppl) 145:A324 (1992).
10. Hardy HL, Tabershaw IR. Delayed chemical pneumonitis in workers exposed to beryllium compounds. J Ind Hyg Toxicol 28:197-211 (1946).
11. Hardy HL. Clinical and epidemiologic aspects. In: Pneumoconiosis. Sixth Saranac Symposium, Saranac Lake, New York, 1947 (Vorwald AJ, ed). New York:Paul B. Hoeber, 1950;133-151.
12. Hardy HL. The disability found in persons exposed to certain beryllium compounds. AMA Arch Ind Health 12:174-181 (1955).
13. Kanarek DJ, Wainer RA, Chamberlin RI, Weber AL, Kazemi H. Respiratory illness in a population exposed to beryllium. Am Rev Respir Dis 108:1295-1302 (1973).
14. Wright GW, Filley GF, Proemmel D, Princi F, Place R, Grinnel R. Observations concerning the pathological physiology underlying exertional dyspnea in the disease "granulomatosis occurring in beryllium workers." Symposium on Military Physiology Digest Series 4:135-146 (1947).
15. Wright GW. Chronic pulmonary granulomatosis of beryllium workers. Trans Am Clin Climatol Assoc 61:166-180 (1949).
16. Sprince NL, Kanarek DJ, Weber AL, Chamberlin RI, Kazemi H. Reversible respiratory disease in beryllium workers. Am Rev Respir Dis 117:1011-1017 (1978).
17. Nishikawa S, Hirata T, Kitaichi M, Izumi T. Three years prospective study of mantoux reactions in factory workers exposed to beryllium oxide. In: Sarcoidosis and Other Granulomatous Diseases (Jones-Williams W, Davies BH, eds). Cardiff, Wales:Alpha Omega Publishing, 1980;722-727.
18. Stoeckle JD, Hardy HL, Weber AL. Chronic beryllium disease: long-term follow-up of six cases and selective review of the literature. Am J Med 46:545-561 (1969).
19. Peyton MF, Worcester J. Exposure data and epidemiology of the beryllium case registry - 1958. AMA Arch Ind Health 19:94-99 (1959).
20. Seeler AO. Treatment of chronic beryllium poisoning. AMA Arch Ind Health 19:164-168 (1959).
21. Hardy HL, Rabe EW, Lorch S. U.S. Beryllium Case Registry (1952-1966): review of its methods and utility. J Occup Med 9:271-276 (1967).
22. Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman LS. Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol 88:54-60 (1991).
23. Newman LS. Significance of the blood beryllium lymphocyte proliferation test. Environ Health Perspect 104(Suppl 5):953-956 (1996).
24. Pappas GP, Newman LS. Early pulmonary physiologic abnormalities in beryllium disease. Am Rev Respir Dis 148:661-666 (1993).
25. Newman LS, Buschman DL, Newell JD Jr, Lynch DA. Beryllium disease: assessment of CT. Radiology 190:835-840 (1994).
26. Newman LS, Orton R, Kreiss K. Serum angiotensin converting enzyme activity in chronic beryllium disease. Am Rev Respir Dis 146:39-42 (1992).
27. Bost TW, Riches DWH, Schumacher B, Carré PC, Kahn TZ, Martinez JAB, Newman LS. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for TNF-α and IL-6 but not IL-1β. Am J Respir Cell Mol Biol 10:506-513 (1994).
28. Newman LS, Bobka C, Schumacher B, Daniloff E, Zhen B, Mroz MM, King TE Jr. Compartmentalized immune response reflects clinical severity of beryllium disease. Am J Respir Crit Care Med 150:135-142(1994).
29. Epstein PE, Dauber JH, Rossman MD, Daniele RP. Bronchoalveolar lavage in a patient with chronic berylliosis: Evidence for hypersensitivity pneumonitis. Ann Intern Med 97:213-216 (1982).